cancer
The current results of the study are very promising and pave the way for a change in surgical strategy in the treatment of these tumors, which would involve a treatment of local chemo-radiotherapy and minimal local surgery, preserving the rectum.
read more
Tricin as a potential enhancer for the treatment of cisplatin-based skin cancer
Tricin as a potential enhancer for the treatment of cisplatin-based skin cancer https://www.tauli.cat/institut/wp-content/uploads/2020/06/1593154770_tmp_IMG_1783-e1593155055158.jpg 585 409 Guillem Cebrian Guillem Cebrian https://www.tauli.cat/institut/wp-content/uploads/2020/02/IMG-1030-150x150.png
By: Guillem Cebrian
At the end of December 2019, we talked about the effectiveness of trichina as an adjuvant of cisplatin in treatment. Squamous cell carcinoma is the second most common type of skin cancer. It causes the abnormal growth of squamous cells in the epidermis and represents 20-25% of all skin cancers in Spain. This study led by an I3PT team, led by Sílvia Gil, in close collaboration with…
read moreTaby Diagnostics wins the 3rd prize of the EIT Health Cross-KIC-Business Idea Competition 2018
Taby Diagnostics wins the 3rd prize of the EIT Health Cross-KIC-Business Idea Competition 2018 https://www.tauli.cat/institut/wp-content/uploads/2020/02/Final_EIT-Health_Business-Idea-Competition2018_sized-1024x659.jpg 1024 659 Xavier Gallego Xavier Gallego https://www.tauli.cat/institut/wp-content/uploads/2019/11/Xavi-150x150.jpg
By: Xavier Gallego
Jointly organized by EIT Health, EIT Raw Materials, and EIT Food, the Business Idea Competition helps to improve cross-sectoral innovation performance in EIT RIS countries along the following thematic areas: 1) Food, 2) Health, and 3) Raw Materials.
read more- 1
- 2